Skills and Training

Technical (Statistical, Programming and pharmaceutical)

• Data Science Specialization by Johns Hopkins University. (9 courses: Developing Data Products, Practical Machine Learning, Regression Models, Statistical Inference, Exploratory Data Analysis, Getting and Cleaning Data, Reproducible Research, R Programming, and The Data Scientist’s Toolbox)
• Machine Learning (Stanford University) – In progress
• 2nd ECO Winter school – In vitro and In silico toxicology (Madrid, February 2012)
• 3rd Strasbourg summer school on chemoinformatics (Strasbourg, June 2012)
• Verona school on chemoinformatics (Verona, June 2012)
• 3rd ECO Winter school (Kalmar, February 2013)
• Spring school in Bioinformatics (Hohenkammer, 2010)
• European Patent Academy Workshop (Munich, 2010)
• SimCYP PBPK modeling (Konstanz, 2011)
• Research management training (ReMaT)
• Microsoft Certified Solution Developer (288-hour course)
• Using R for statistical data analysis (TUM)
• Microsoft Certified Professional (MCP) in Designing and Implementing Databases with Microsoft® SQL Server™ Enterprise Edition
• Drug Design/Computational Chemistry packages: Molecular Operating Environment (MOE), Simcyp, GastroPlus, ADMET Predictor, ChemBio Office, WinNonLin, Chemaxon Jchem/Marvin, CDD Vault
• Analytics and Statistical packages: R, WEKA, Orange, qtiPlot, SPSS, PSPP, tableau
• Programming languages: Java, C#, ASP.NET, R and PHP
• Database systems: MS SQL Server, MySQL, MongoDB, Hadoop Map/Reduce, Amazon S3, Postgre, and Oracle PL/SQL.
• IDEs: Eclipse, Visual Studio, Adobe Dreamweaver

Managerial

• Teamentwicklung und Personalmanagement (Berlin, December 2013)
• E-Camp! Enterprising Knowledge (TUM, September 2013)
• ”Conflict Management” 16 hour (Creative dialogue, June 2013)
• IP und Unternehmensübernahme, Kunden- und Investorn-Ansprache (Berlin, December 2012)
• Präsentationstecknik, Kunden- und Investorn-Ansprache (Berlin, May 2012)
• Presenting and arguing – rhetoric training (HMGU)
• Research management training (ReMaT, HMGU)
• Intellectual property management workshop by WIPO (May 2009, Cairo, Egypt)
• Communicating with Influence (16 hour NLP training) by GUC (April 2009, Cairo, Egypt)
• Business planning training by MIT Arab Chapter (March 2009, Beirut, Lebanon)
• Business planning training by UNIDO (September 2007, Bahrain)
• Presentation Skills (12-hour) (American university in Cairo)

Associations

• IEEE (Institute of Electrical and Electronics Engineers)
• FIP (International Pharmaceutical Federation) (Industrial & Academic pharmacy sections)
• ACS (American Chemical Society)

peer reviewed publications

• Ahmed Abdelaziz, et al: “Using Online Tool (iPrior) for Modeling ToxCast™ Assays Towards Prioritization of Animal Toxicity Testing” Comb. Chem. High Throughput Screen 2015
• Sushko Y, Novotarskyi S, Körner R, Vogt J, Abdelaziz A, Tetko I V: Prediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization process. J Cheminform 2014, 6:48.
• Mumbo J, Henkelmann B, Abdelaziz A, Pfister G, Nguyen N, Schroll R, Munch JC, Schramm K-W: Persistence and dioxin-like toxicity of carbazole and chlorocarbazoles in soil. Environ Sci Pollut Res Int 2014.
• Brandmaier, Stefan, et al. “The QSPR-THESAURUS: The online platform of the CADASTER project.” Alternatives to laboratory animals: ATLA 42.1 (2014): 13-24.
• Sushko, Iurii, et al. “Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information.” Journal of computer-aided molecular design 25.6 (2011): 533-554.

Talks/Invited Lectures

• QSAR modeling for the evaluation of Aryl Hydrocarbon receptor activators; and
• Analyzing Toxcast Phase I HTS assays as a potential descriptors (ECO closing conference, September 2013)
• SAR in the cloud; OCHEM, a free online platform for modeling and interpretation (EPFL Workshop on chemical information, August 2013)
• QSAR modeling for the evaluation of Aryl hydrocarbon receptor activators (244th ACS meeting, August 2012)
• Combining HTS in vitro assays with in silico descriptors for liver toxicity modeling (244th ACS meeting, August 2012)
• Karl-Franzens-Universität Graz, Inst. Fur Pharmazeutische Wissenschaften Bereich Pharmazeutische Chemie, Graz, Austria
• Drug design summer school 200 7& 2008– Tuebingen, Germany

Scientific Posters

• “Development of classification models for the Aryl Hydrocarbon Receptor (AHR) activators using HTS big dataset: Utilizing applicability domain and addressing unbalance in the dataset” (248th ACS meeting, San Francisco, August 2014)
• “OCHEM: Online public platform for human and environmental toxicity modeling” (248th ACS meeting, San Francisco, August 2014)
  “Matched Molecular Pairs analysis using OCHEM” Iurii Sushko, Ahmed Abdelaziz, …. Igor V. Tetko (50th International Conference on Medicinal Chemistry, July 2014)
• “On-line chemical modeling environment: Public user contributed tools for drug discovery.” Tetko, I.V.; Sushko, I.; Novotarskyi, S.; Körner, R.; Abdelaziz, A. In International Conference on Medicinal Chemistry: RICT2013. July 3-5 2013, Nice France, p. 366.
  “On-line Chemical modeling environment – database and models for physico-chemical properties” Tetko, I.V.; Sushko, I.; Novotarskyi, S.; Körner, R.; Abdelaziz, A. 3rd World Conference on Physico Chemical Methods in Drug Discovery and Development. September 20 -26, 2013, Dubrovnik, Croatia, p. 11.
• “Challenges with development of a melting point model using public data: not all errors are not the same!” Tetko, I.V.; Patiny, L.; Charochkina, L.; Sushko, I.; Abdelaziz, A.; Asiri, A.M. 3rd World Conference on Physico Chemical Methods in Drug Discovery and Development. September 20 -26, 2013, Dubrovnik, Croatia, p. 40.
• “Combining HTS in vitro assays with in silico descriptors for Liver toxicity modeling” Abdelaziz A.; Tetko, I., 244th American Chemical Society meeting (Philadelphia, US, August, 2012)
• “Using Toxcast™ HTS assays as biologically derived descriptors in QSAR” Abdelaziz A.; Tetko, I., 3rd Strasbourg summer school on chemoinformatics, Strasbourg, France, June 2012
• “QSAR modeling for the evaluation of Aryl Hydrocarbon receptor activators” Abdelaziz A.; Alexander Safanayev; Tetko, I., ADME and predictive Toxicology Europe & Munich Interact, Munich, Germany, March 2012
• “QSAR modeling for In vitro assays: linking ToxCast™ database to the integrated modeling framework-OCHEM” Abdelaziz A.; Körner R.; Novotarskyi S.; Teetz W.; Sushko I.; Tetko, I., German Conference on Bioinformatics, Weihenstephan, Germany, 7-9 September 2011
• “Active and Reactive Metabolites Formed During Hepatic First-Pass: Simulations Featuring Their Contribution to the Overall Effect in Altered Liver Clearance and Drug-Drug Interactions” OpenTox 2011 InterAction Meeting Program, Munich, Germany, 9-12 August 2011
  “public QSAR framework with integrated measurements database” Abdelaziz A.; Körner R.; Novotarskyi S.; Teetz W; Pandey A.; Sushko I.; Rupp M.; Tetko, I:OCHEM: Chemaxon eUGM 2011, Budapest, Hungary, 15-20 May 2011
• “Stepwise D-Optimal design based on latent variables” Brandmaier, S.; Abdelaziz, A.; Sahlin, U.; Oberg, T.; Tetko, I., interact 2011 Munich, Munich, Germany, April 7, 2011
• “Prediction of kinetic characteristics of drug metabolites in-silico: The distribution characteristics of beta-adrenoceptor antagonists” Abdelaziz A.; Tetko, I.; Spahn-Langguth H., ADMET Europe 2011, Munich, Germany, 28-29 March 2011
• “OCHEM: public QSAR framework for modeling PK/PD parameters” Abdelaziz A.; Körner R.; Novotarskyi S.; Teetz W; Pandey A.; Sushko I.; Rupp M.; Tetko, I., ADMET Europe 2011, Munich, Germany, 28-29 March 2011
• Active Metabolites Formed During Hepatic First-pass: Modelling Serum Concentration-Time Profiles   [15th Scientific Symposium of the Austrian Pharmacological Society (APHAR)(November 2009 in Graz, Austria)] and [Jahrestagung der DphG 2008 (October 2008 in Bonn, Germany)] and [69th FIP congress (September 2009 in Istanbul, Turkey)]
• Active metabolites formed during hepatic first-pass: Simulations featuring their contribution to the overall effect in altered liver clearance. [Jahrestagung der DGPT 2009 (March 2009 in Mainz, Germany)]

Internships

• Pfizer Global Research Site (Groton, US, March-April 2013)
• CML Leiden University (Leiden, October-December 2012)
• Prof. Spahn-Langguth (Mainz, July-August 2012)

Community activities

• Interdesigns Corporate Social Responsibility program (ongoing)
• Business strategist for 57357 children cancer charity hospital (2009-2010)
• Volunteering in the pharmacy team for ASSPSA medical caravan to offer medical services and screening for epidemics to underprivileged villages in Fayoum, Egypt (2004)
• Ain-Shams advanced pharmaceutical research unit in Bioequivalence studies.

Languages

• English: excellent spoken and written (Toefl iBT: 112)
• German: moderate (B2)
• Arabic: native fluency

Hobbies

Traveling and Programming